Cervical Cancer News & Features

New data from England show the success of the national human papillomavirus (HPV) vaccination program in preventing cervical cancer in young women.

Lacks’s cells, commonly known as “HeLa,” are the only known human cells that continue to stay alive and reproduce outside of the human body. Her cells have been used for decades in medical discoveries and live-saving treatments.

The new guideline calls for an initial cervix screening at age 25, followed by the human papillomavirus (HPV) test every five years, continuing through age 65, the guideline says.

The WHO plan also calls for 70% of women to be screened for cervical cancer once or twice in their lifetime, and for 90% of women with precancerous lesions or cervical cancer to receive appropriate treatment.

Mailing self-sampling kits to test for the cervical cancer-causing virus HPV significantly increased screening rates for the cancer, according to a new study.

As government funding dried up and many women's health clinics across America closed, cervical cancer screening rates fell and deaths from the disease rose, a new report shows.

HPV vaccination programs significantly reduce  human papillomavirus infections and precancerous cervical lesions, a new global review finds.

Women with the high-grade pre-cancerous cervical lesions had a more abundant and diverse mix of bacteria in their cervical microbiomes than women who had no lesions or less serious lesions, according to the study published recently in the journal mBio.

Researchers said the finding point to what's called "herd protection" -- where everyone benefits from having a large portion of the population vaccinated against a particular disease.

In 2016, just over half of U.S. women aged 21 to 29 and less than two-thirds of women aged 30 to 65 were up-to-date with cervical cancer screenings, according to a new report.

If a woman has one negative HPV DNA test at the age of 55, she probably has a very low risk of cervical cancer, and continued HPV screening would offer little benefit, according to a new study.

Two new studies have found that the routinely used minimally invasive surgery for early stage cervical cancer is linked to a higher rate of recurrence, plus worse long-term survival, compared with more "open" surgeries.

For decades, the Pap smear has been the standard way to test for cervical cancer. But under new government guidelines, women over 30 will have options: a pap test every three years, a test for the human papilloma virus every five years, or both tests together every five years.

Moderate cervical lesions -- formally known as cervical intra-epithelial neoplasia grade 2 (CIN2) -- are abnormal cells on the surface of the cervix.

Death rates from cervical cancer have fallen by more than 50 percent in the past four decades as women have learned more about their risk and as increasing numbers have had Pap tests, which help doctors screen for the disease, the experts noted.

New advisory says women can get the screen once every 5 years, in lieu of Pap tests every 3 years

Less testing could reduce risk of false positives and save money, researchers say

But study found just 30 minutes of exercise a week might lower chances of disease

For women 21 years and older at average risk for cervical cancer, getting screened once every 3 years should suffice, according to advice from the American College of Physicians (ACP).

Two groups call it an effective alternative to the Pap test, but another group disagrees

Gardasil 9 protects against 9 types of the virus, compared to the 4 covered by Gardasil

CDC report notes that half of cases occur among women never or rarely screened

More than 4,000 women projected to die this year from the disease

Study of over 1 million women suggests it could be stand-alone screening method

Analysis included more than 500,000 women from Denmark